Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies.

Therapeutic Advances in Neurological Disorders
Pietro IaffaldanoItalian MS Register

Abstract

No consensus exists on how aggressively to treat relapsing-remitting multiple sclerosis (RRMS) nor on the timing of the treatment. The objective of this study was to evaluate disability trajectories in RRMS patients treated with an early intensive treatment (EIT) or with a moderate-efficacy treatment followed by escalation to higher-efficacy disease modifying therapy (ESC). RRMS patients with ⩾5-year follow-up and ⩾3 visits after disease modifying therapy (DMT) start were selected from the Italian MS Registry. EIT group included patients who received as first DMT fingolimod, natalizumab, mitoxantrone, alemtuzumab, ocrelizumab, cladribine. ESC group patients received the high efficacy DMT after ⩾1 year of glatiramer acetate, interferons, azathioprine, teriflunomide or dimethylfumarate treatment. Patients were 1:1 propensity score (PS) matched for characteristics at the first DMT. The disability trajectories were evaluated by applying a longitudinal model for repeated measures. The effect of early versus late start of high-efficacy DMT was assessed by the mean annual Expanded Disability Status Scale (EDSS) changes compared with baseline values (delta-EDSS) in EIT and ESC groups. The study cohort included 2702 RRMS patients. The P...Continue Reading

References

Mar 3, 2006·The New England Journal of Medicine·Richard A RudickUNKNOWN SENTINEL Investigators
Mar 25, 2009·Journal of Neurology·Michael HutchinsonUNKNOWN AFFIRM and SENTINEL Investigators
Jan 22, 2010·The New England Journal of Medicine·Jeffrey A CohenUNKNOWN TRANSFORMS Study Group
Mar 26, 2011·Journal of Neurology, Neurosurgery, and Psychiatry·G EdanUNKNOWN French–Italian Mitoxantrone Interferon-beta-1b Trial Group
May 30, 2014·Neurology·Fred D LublinChris H Polman
Dec 30, 2014·Annals of Neurology·Tomas KalincikUNKNOWN MSBase Study Group
May 28, 2016·Multiple Sclerosis : Clinical and Laboratory Research·Damiano BaronciniGiancarlo Comi
Dec 22, 2016·The New England Journal of Medicine·Stephen L HauserUNKNOWN OPERA I and OPERA II Clinical Investigators
Jan 14, 2017·Nature Reviews. Neurology·Maria TrojanoHelmut Butzkueven
Feb 1, 2017·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·O FernándezG Comi
Sep 1, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Tomas KalincikUNKNOWN MSBase Study Group
Jan 23, 2018·Multiple Sclerosis : Clinical and Laboratory Research·Xavier MontalbanFrauke Zipp
Nov 15, 2018·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Maria TrojanoUNKNOWN Italian Multiple Sclerosis Register Centers Group
Jan 16, 2019·JAMA : the Journal of the American Medical Association·J William L BrownUNKNOWN MSBase Study Group
Apr 4, 2019·Nature Reviews. Neurology·Dalia Rotstein, Xavier Montalban
Apr 3, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Luca ProsperiniClaudio Gasperini

❮ Previous
Next ❯

Citations

Sep 3, 2021·Multiple Sclerosis : Clinical and Laboratory Research·Hans-Peter HartungAlan J Thompson

❮ Previous
Next ❯

Software Mentioned

SAS
R
DELIVER
IMSR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of Managed Care
Katia Noyes, Bianca Weinstock-Guttman
European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
L H Visser, A van der Zande
© 2021 Meta ULC. All rights reserved